Lash serum and your eyelids: bimatoprost, sunken or darker lids, and what recovers after stopping
Some lash serums contain a prostaglandin medicine, and some hide it. Here is what it can do to the eyelids, which changes settle after stopping, and when to see an eye doctor.
Consultant Ophthalmologist and Oculoplastic Surgeon · MMC 66025 · NSR 143681 · Consultations from early 2027
- Lash serums that contain a prostaglandin analogue such as bimatoprost can cause prostaglandin-associated periorbitopathy: a deeper upper lid groove, a lower or tighter lid and darker lid skin.
- The bimatoprost lash label expects lid skin darkening and lash changes to reverse over weeks to months, but says iris darkening is not expected to reverse and is likely permanent.
- Fat loss around the eye often improves after the drug stops, but only partly in some people, and evidence for cosmetic serums is mostly case reports.
- In a Japanese test of 64 serums bought online, four contained bimatoprost and three of those four did not list it; a French study of 79 products found about 30 per cent held a prostaglandin analogue.
- Stop the serum and see an eye doctor if a lid hollows, darkens or lowers, but do not stop a prescribed glaucoma drop on your own.
A lash serum is sold as a beauty product, but some of them contain a medicine. The active ingredient bimatoprost, and its relatives, belong to the prostaglandin analogue class, the same class as the most common glaucoma drops. This page is for the person who bought a serum, or a prescription lash solution, and now sees a hollow upper lid, darker lid skin or a lid that sits lower. It sets out what the evidence says, what tends to settle after stopping, and when to see an eye doctor.
Can a lash serum change the look of my eyelids?
Yes, the prostaglandin type can. The changes are the ones described for glaucoma drops, called prostaglandin-associated periorbitopathy, or PAP: changes in the tissues around the eye linked to prostaglandin analogues. The US prescribing label for bimatoprost 0.03% eyelash solution lists, among reports made after approval, periorbital and lid changes with fat atrophy and skin tightness that deepen the eyelid sulcus, and eyelid ptosis, the medical name for a droopy lid. The sulcus is the groove between the lid and the brow bone.
A 2026 review in the Journal of Cosmetic Dermatology by Kaufman and colleagues says PAP is well recognised in ophthalmology but that dermatology data are sparse, and that evidence for cosmetic lash and eyebrow serums is limited and mostly case reports. Be clear about what that means. These changes are real and listed on the label, but nobody can give you a rate for lash serums, and I will not invent one. In my own page on glaucoma drops and your eyelids I set out the larger body of evidence from people who use the drop for pressure control.
What can it do to the eyelids, and which changes are which?
Five things are described, and they behave differently. Keeping them apart is the point of this page.
First, a deeper upper lid groove and a hollow look. The likely cause is shrinkage of the fat around the eye, the orbital fat, which is soft padding in the bony socket. The lid and eye then sit on less support. Second, a lid that sits lower, or looks tighter, which the label also lists. A droop of this kind is one cause of ptosis that is not ageing, which I cover in my article on ptosis that is not ageing.
Third, darker lid skin. The label says bimatoprost can darken the pigmented tissue around the eye, and that this has been reported to be reversible on stopping in most people. Fourth, irritation: redness of the white of the eye, itch and redness along the lid. In a pooled safety analysis of six randomised trials of bimatoprost 0.03% for lash hypotrichosis, the common events were conjunctival hyperaemia, lid itch, lid pigmentation and lid redness, mostly mild and local, and the authors report they were reversible on stopping. Stopping because of side effects was uncommon, 3.2 per cent on the drug against 2.4 per cent on the vehicle.
Fifth, a change in iris colour. The label advises that brown pigmentation of the iris can increase and is likely to be permanent. The pooled analysis recorded iris pigmentation in two people, both described as mild. It is uncommon in the trials, but because it may not reverse, it is the one change to take seriously before you begin.
Which changes settle after I stop, and which may not?
Skin darkening and lash changes are expected to settle, fat loss often partly recovers, and iris darkening is not expected to reverse. That summary comes with limits, so here is the detail.
For lash growth, the label says lashes are expected to return to their previous appearance over several weeks to months, and that lid skin darkening is expected to reverse over a similar period. For the iris, the same label says any darkening is not expected to reverse and is likely permanent.
For fat loss, most of the data come from glaucoma patients. In a Turkish series, nine people with PAP who stopped a prostaglandin drop for cosmetic reasons showed improvement in the deepened sulcus and fat pad one year later, with the upper sulcus better in 8 of 10 eyes and the lower lid fat partly back in 4. The sample is small and recovery was partial, and a full return cannot be counted on. The Kaufman review describes one case of lash serum use in which hollowing improved over six months after stopping, and also stresses that how much recovers depends on how long the product was used and how potent it was. EyeWiki and Medsafe, writing about glaucoma drops, say changes may be partly or fully reversible, and Medsafe adds that they can start as early as one month. Neither is a promise, and neither describes a cosmetic serum.
So the honest answer is that most people can expect the skin and lash effects to fade, many see the hollowing improve, and nobody can tell you beforehand how much. EyeWiki also says surgery, filler or fat grafting is not recommended for PAP itself, since the signs seem to settle when the drug stops. Waiting and reviewing comes first.
Can a cosmetic serum hide a prostaglandin?
It can. Two laboratory studies show that serums sold as cosmetics sometimes contain prostaglandin analogues, and that the label does not always say so.
In Japan, researchers bought 64 eyelash serums from 34 websites and tested them by liquid chromatography and mass spectrometry. Four contained bimatoprost, and three of those four did not list it on the packaging. Eight more contained other prostaglandin analogues that have never been used as medicines. None held latanoprost, travoprost or tafluprost, the glaucoma drops. In France, a qualitative study of 79 lash products found that about 30 per cent contained a prostaglandin analogue. Six different analogues were found, including bimatoprost and norbimatoprost, and the most common were ethyl tafluprostamide and isopropyl cloprostenate. The authors note these products are not regulated for use in cosmetics.
These are samples from two countries, not a survey of Malaysia, and I do not know what is on any particular shelf here. What you can do is read the ingredient list for names that contain "prost", such as isopropyl cloprostenate or ethyl tafluprostamide. A list without such a word does not prove the product is free of them, as the Japanese result shows. A serum that claims to grow lashes noticeably, with no named active, deserves caution for that reason.
What should I do if I notice a change?
Stop the serum and see an eye doctor, ideally one who looks after eyelids. If you were prescribed bimatoprost for your lashes, speak to the prescriber before you stop. If you use a prostaglandin glaucoma drop as well, do not stop that drop on your own. The label says people already using these drops for eye pressure should only use the lash product after talking to their doctor, because it may interfere with the pressure-lowering effect.
Take dated photographs from the front and side, in the same light, and bring the bottle or a photograph of the ingredient list. A review of the cosmetic literature argues that doctors should ask routinely about lash and eyebrow serums, because the question is often missed. Say that you use one, even if you think it is only a cosmetic.
If you also have a red, itchy or swollen lid, the cause may be an allergy to glue, preservatives or the serum, not PAP. I set that question out in my article on allergic eyelid reactions to lash extensions and cosmetics. Dr Ong Jin Khang at The Retreat Clinic covers the cosmetic side, what lash extensions, lash serums and eye makeup do to the eyelid. If your lashes are thinning rather than lengthening, my article on eyelash and eyebrow loss lists other causes.
When should I see an oculoplastic surgeon?
See one if a lid is lowering enough to block your upper vision, if a hollow or asymmetry persists after you have stopped for a few months, or if you are thinking about eyelid surgery or filler to fix the change. An oculoplastic surgeon, a specialist in the eyelids, tear ducts and socket, can tell PAP from ageing, ptosis, a sunken eye from other causes, or thyroid eye disease. I explain how one eye can look sunken for other reasons in my article on one eye that looks sunken.
Before any lid operation, tell the surgeon about every serum and drop you use. A second opinion before eyelid or orbital surgery is reasonable when the history is mixed. For the wider picture of why eyes look tired, see my guide to tired-looking eyes, and my eyelid conditions page sets out how lids are assessed.
Dr Catherine Chow will begin consulting at Eagle Eye Centre Malaysia in Petaling Jaya in early 2027. This article is general education and cannot say whether a serum has caused any change in your own eyes.
- A lid is lowering enough to block your upper vision.
- One eye looks sunken, or a hollow is getting worse, while you use a lash serum.
- The colour of your iris seems to be changing.
- Your eye is painful, red or the vision is blurred.
- You also use a prostaglandin glaucoma drop. Do not stop it yourself, but tell your glaucoma doctor about the serum.
Questions patients ask
Yes, if it contains a prostaglandin analogue such as bimatoprost. The US label for bimatoprost lash solution lists periorbital fat atrophy and a deeper eyelid sulcus among reports after approval. Evidence for cosmetic serums is mostly case reports, so no rate can be given.
It can. The label says it may darken pigmented tissue around the eye, and that this has been reported to be reversible on stopping in most people. Lid skin darkening is expected to fade over several weeks to months.
The prescribing label says brown iris pigmentation can increase and is likely to be permanent. In a pooled analysis of six trials it was reported in two people, both mild. Tell an eye doctor if your iris colour seems to change.
Skin darkening and lash changes are expected to settle. Fat loss often improves, as in a small Turkish series at one year, but only partly in some people. Nobody can say beforehand how much will recover.
Some do. A Japanese study of 64 serums bought online found bimatoprost in four, and three did not list it on the label. A French study of 79 products found about 30 per cent contained a prostaglandin analogue, of six different kinds.
Read the ingredient list for names that contain prost, such as isopropyl cloprostenate or ethyl tafluprostamide. A clean list does not prove absence, because the Japanese study found undeclared bimatoprost. A serum with no named active that grows lashes noticeably deserves caution.
Only after speaking to your doctor. The label says people using prostaglandin analogues to lower eye pressure should use the lash product only after consulting their physician, because it may interfere with the pressure-lowering effect. Never stop a glaucoma drop on your own.
Not as a first step. EyeWiki says surgery, filler or fat grafting is not currently recommended for PAP itself, since the signs seem to settle when the drug stops. Stop the product, have the lid reviewed and wait before deciding.
Sources
- FDA prescribing information: bimatoprost ophthalmic solution 0.03% for eyelash hypotrichosis (NDA 022369, 2021 label) (opens in a new tab)
- Kaufman L, et al. Periorbital fat loss from prostaglandin analogues: dermatologic and cosmetic considerations. J Cosmet Dermatol 2026 (opens in a new tab)
- Rahman MS, et al. Screening and quantification of undeclared PGF2alpha analogs in eyelash-enhancing cosmetic serums using LC-MS/MS. J Pharm Biomed Anal 2022 (opens in a new tab)
- Couteau C, Coiffard L. Prostaglandin analogues in cosmetic products formulated for eyelash lengthening. Ann Pharm Fr 2026 (opens in a new tab)
- Bimatoprost 0.03% for eyelash hypotrichosis: a pooled safety analysis of six randomized trials. J Clin Aesthet Dermatol 2015 (opens in a new tab)
- Improvement of prostaglandin-associated periorbitopathy after discontinuing treatment. Turk J Ophthalmol 2023 (opens in a new tab)
- Medsafe Prescriber Update: Prostaglandin-associated periorbitopathy (September 2022) (opens in a new tab)
- EyeWiki (AAO): Prostaglandin Associated Periorbitopathy (opens in a new tab)
General information written by a consultant oculoplastic surgeon. It does not replace an examination. If you are worried about your eyes or eyelids, please see an eye doctor. Written and reviewed by Dr Catherine Chow, Consultant Ophthalmologist and Oculoplastic Surgeon, MMC 66025 · NSR 143681.
Glaucoma drops and your eyelids: a sunken upper lid, longer lashes and a droopy look
Some glaucoma drops change the look of the eyelids as well as the eye pressure. Here is what people notice, what the sources say about how common it is and whether it reverses, and why you should never stop the drops on your own.
Read the articleWhat are the risks and complications of ptosis surgery? Overcorrection, a lid that will not close, dry eye and asymmetry
Diabetes and the eyelids: recurrent styes, a droopy lid and healing before eyelid surgery
Revision double eyelid surgery: when a crease is too high, uneven, fading or doubled, and what a second operation can and cannot do
Bring the midnight questions.
Researching quietly is smart. When you're ready to ask out loud, Dr Catherine Chow will consult at Eagle Eye Centre Malaysia, Petaling Jaya, from early 2027.
Until then, you can follow her on Instagram, @drcatherinec (opens in a new tab).















